2016-05-21 17:31:17 Challenge: Med Labs has derived a new drug to treat chronic lymphocytic leukemia. However, it doesn’t possess the connections to avail test patients who can try the drug, to assess its effectiveness. More the delay in identifying a target patient group, more will be the delay in releasing the drug to the market. If Med Labs can’t move in before its other competitors to capture the market, it will incur huge losses for all the resource investment in R&D and testing. Solution: “Patient Identification and Cohort Discovery” maintains a repository of patients’ medical records across medical institutions and hospitals. It can browse through these files to look for a match of patients having similar symptoms. It can establish initial contact to gauge the interest levels of the patients. If found favorable, it shares the final list of patients who can serve as the target test group. Result: Med Labs can now use this solution to identify its patients and establish further contact to progress with the final tests. This process will take comparatively very less time.
.